Provided by Tiger Trade Technology Pte. Ltd.

REMEGEN

79.350
-1.350-1.67%
Volume:1.99M
Turnover:158.03M
Market Cap:44.72B
PE:52.74
High:80.950
Open:80.950
Low:78.800
Close:80.700
52wk High:126.600
52wk Low:63.300
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:0.49
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.505
ROE:109.10%
ROA:39.01%
PB:4.61
PE(LYR):52.74
PS:4.79

Loading ...

Stock Track | REMEGEN Soars 10.04% Intraday on Strong Annual Results and Profit Turnaround

Stock Track
·
Mar 30

REMEGEN Shares Surge Over 8% Following Strong Annual Results Showing Profit Turnaround

Stock News
·
Mar 30

Compensation Data Revealed for 68 Pharmaceutical Firms

Deep News
·
Mar 28

Remegen Co.,Ltd. Board Approves Multiple Proposals Including the 2025 General Manager Work Report

Deep News
·
Mar 27

REMEGEN Reports Annual Profit of 710 Million Yuan, Turning Around from Prior Year Loss

Stock News
·
Mar 27

HK Pharma Stocks Gained. CSPC Pharma Up 13%; Lepu Bio Up 7%; Hengrui Pharma And Junshi Bio Up 6%; HBM, Beigene, Sihuan Pharm Up 5%

Tiger Newspress
·
Mar 27

HK Pharma Stocks Gained. XuanzhuBio Up 9%; Xtalpi, Lepu Bio And Ascletis Up 6%; Akeso Up 5%; Skb Bio Up 4%.

Tiger Newspress
·
Mar 26

REMEGEN Shares Climb Over 5% as Disitamab Vedotin Gains Fourth Indication Approval

Deep News
·
Mar 24

HK Pharma Stocks Gained. Wuxi XDC Up 8%; Wuxi AppTec Up 7%; Transthera And HBM Up 5%; Keymed Bio And Innocare Up 4%; Wuxi Bio And Remegen Up 3%

Tiger Newspress
·
Mar 24

Remegen's ADC Therapy Disitamab Vedotin Secures Approval for New Breast Cancer Indication

Stock News
·
Mar 23

Hong Kong Market Rebounds as Tech Stocks Revive Amid Complex Middle East Conflict

Stock News
·
Mar 18

Revised title

Stock News
·
Mar 18

REMEGEN (09995) Sets 27 Mar 2026 Board Meeting to Review FY2025 Results and Dividend Proposal

Bulletin Express
·
Mar 17

HK Movers | Biotech Stocks Jump. Wuxi XDC up 7%; Junshi Bio up 6%; Remegen, Genscript Bio, Wuxi Apptec up around 5%; Innocare up over 4%.

Tiger Newspress
·
Mar 17

Assessing RemeGen (SEHK:9995) Valuation After Its Turnaround To Full-Year Profit

Simply Wall St.
·
Mar 14

Brain-Computer Interface Concept Resurfaces, Stablecoin Licenses Imminent

Stock News
·
Mar 13

REMEGEN Shares Climb Over 5% Following Regulatory Acceptance of RC288 Application

Stock News
·
Mar 13

RemeGen Shares Surge Over 6% on Strong 2025 Profit Turnaround and Projected Cash Boost

Stock News
·
Mar 06